Literature DB >> 19323955

Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus.

Paolo Monti1, Anne-Kristin Heninger, Ezio Bonifacio.   

Abstract

Autoreactive T cells play a major role in the pathogenesis of type 1 diabetes mellitus (T1DM) and are considered a major target of immunomodulatory strategies aimed at preventing or delaying the disease onset. However, the T-cell response against insulin-producing beta cells is still poorly understood. T cells potentially able to recognize and destroy beta cells are present in most individuals, but only in a few do they differentiate into pathogenic effectors. Recent and novel findings in T-cell biology on the dynamics of T-cell activation and memory maintenance are shedding new light on the general mechanisms of the T-cell response. In this article, we discuss how new discoveries about T-cell differentiation, expansion, and homeostasis could help to clarify mechanisms of autoimmunity that lead to T1DM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19323955     DOI: 10.1007/s11892-009-0020-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  42 in total

1.  Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation.

Authors:  E Bonifacio; M Scirpoli; K Kredel; M Füchtenbusch; A G Ziegler
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

2.  Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate.

Authors:  Steven L Reiner; Federica Sallusto; Antonio Lanzavecchia
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

3.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.

Authors:  Milica Vukmanovic-Stejic; Yan Zhang; Joanne E Cook; Jean M Fletcher; Arthur McQuaid; Joanne E Masters; Malcolm H A Rustin; Leonie S Taams; Peter C L Beverley; Derek C Macallan; Arne N Akbar
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.

Authors:  K S Schluns; W C Kieper; S C Jameson; L Lefrançois
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

5.  Diabetes Antibody Standardization Program: first assay proficiency evaluation.

Authors:  Polly J Bingley; Ezio Bonifacio; Patricia W Mueller
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

Review 6.  Type 1 diabetes as a relapsing-remitting disease?

Authors:  Matthias von Herrath; Srinath Sanda; Kevan Herold
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

Review 7.  Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

Authors:  T P Di Lorenzo; M Peakman; B O Roep
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

8.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

9.  Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development.

Authors:  Qibin Leng; Yuchun Nie; Yongrui Zou; Jianzhu Chen
Journal:  BMC Immunol       Date:  2008-09-15       Impact factor: 3.615

10.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more
  18 in total

1.  Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes.

Authors:  Elena Matteucci; Massimo Ghimenti; Serena Di Beo; Ottavio Giampietro
Journal:  J Clin Immunol       Date:  2011-09-02       Impact factor: 8.317

2.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 3.  T memory stem cells in health and disease.

Authors:  Luca Gattinoni; Daniel E Speiser; Mathias Lichterfeld; Chiara Bonini
Journal:  Nat Med       Date:  2017-01-06       Impact factor: 53.440

Review 4.  Recurrence of autoimmunity following pancreas transplantation.

Authors:  George W Burke; Francesco Vendrame; Antonello Pileggi; Gaetano Ciancio; Helena Reijonen; Alberto Pugliese
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 5.  Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.

Authors:  Rachel J Fenske; Michelle E Kimple
Journal:  Exp Biol Med (Maywood)       Date:  2018-03-04

6.  Decreased expression of programmed death-1 on CD8+ effector memory T lymphocytes correlates with the pathogenesis of type 1 diabetes.

Authors:  Yimei Shan; Yinghong Kong; Yan Zhou; Jingjing Guo; Qiyun Shi; Sicheng Li; Heming Guo; Yiting Huang; Sisi Ding; Cuiping Liu; Lei Cao; Yun Huang; Chen Fang; Ji Hu
Journal:  Acta Diabetol       Date:  2021-04-23       Impact factor: 4.280

Review 7.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  Interleukin-7 and type 1 diabetes.

Authors:  Paolo Monti; Ezio Bonifacio
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

9.  Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.

Authors:  V M de Jong; A R van der Slik; S Laban; R van 't Slot; B P C Koeleman; A Zaldumbide; B O Roep
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

Review 10.  Autoreactive T cells in type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2017-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.